Cover Image

Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial

CC BY

Saved in:
Bibliographic Details
Main Authors: Ignacio, Martin-Loeches, Andrew F., Shorr, Richard G., Wunderink
Format: Book
Language:English
Published: Springer 2023
Subjects:
pivotal ASPECT-NP tria
ventilator-associated bacterial pneumonia
Online Access:https://link.springer.com/article/10.1186/s13613-022-01084-8
https://dlib.phenikaa-uni.edu.vn/handle/PNK/7068
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:localhost:PNK-7068
record_format dspace
spelling oai:localhost:PNK-70682023-03-22T09:08:46Z Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial Ignacio, Martin-Loeches Andrew F., Shorr Richard G., Wunderink pivotal ASPECT-NP tria ventilator-associated bacterial pneumonia CC BY The pivotal ASPECT-NP trial showed ceftolozane/tazobactam was non-inferior to meropenem for the treatment of ventilated hospital-acquired/ventilator-associated bacterial pneumonia (vHABP/VABP). Here, we evaluated treatment outcomes by degree of respiratory or cardiovascular dysfunction. 2023-03-22T09:08:46Z 2023-03-22T09:08:46Z 2023 Book https://link.springer.com/article/10.1186/s13613-022-01084-8 https://dlib.phenikaa-uni.edu.vn/handle/PNK/7068 en application/pdf Springer
institution Digital Phenikaa
collection Digital Phenikaa
language English
topic pivotal ASPECT-NP tria
ventilator-associated bacterial pneumonia
spellingShingle pivotal ASPECT-NP tria
ventilator-associated bacterial pneumonia
Ignacio, Martin-Loeches
Andrew F., Shorr
Richard G., Wunderink
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial
description CC BY
format Book
author Ignacio, Martin-Loeches
Andrew F., Shorr
Richard G., Wunderink
author_facet Ignacio, Martin-Loeches
Andrew F., Shorr
Richard G., Wunderink
author_sort Ignacio, Martin-Loeches
title Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial
title_short Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial
title_full Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial
title_fullStr Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial
title_full_unstemmed Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial
title_sort outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled aspect-np trial
publisher Springer
publishDate 2023
url https://link.springer.com/article/10.1186/s13613-022-01084-8
https://dlib.phenikaa-uni.edu.vn/handle/PNK/7068
_version_ 1761097142432169984
score 8.891053

Similar Items